FDA Inspection 848700 — Rising Pharmaceuticals, Inc.

Rising Pharmaceuticals, Inc. — FEI 3004813192

The FDA completed an inspection of Rising Pharmaceuticals, Inc. on Sep 16, 2013 in Saddle Brook, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 16, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saddle Brook, NJ (United States)

Citations

IDCFRDescription
1583821 CFR 111.70(d)Specifications - labels, packaging
1583921 CFR 111.70(e)Specifications - identity, purity, strength, composition
1586321 CFR 111.75(a)(2)(ii)(B)Component - certificate of analysis

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.